Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder

Annals of Pharmacotherapy

Volumn 38, Issue 11, 2004, Pages 1852-1854

  Malek Ahmadi, Parviz ^a   Hanretta, Allan T ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Oxcarbazepine; Posttraumatic stress disorder

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; LAMOTRIGINE; MIRTAZAPINE; OLANZAPINE; OXCARBAZEPINE; PANTOPRAZOLE; PAROXETINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR II DISORDER; CASE REPORT; COMORBIDITY; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FACE EDEMA; FEMALE; HUMAN; MONOTHERAPY; MOOD; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL;

ADULT; BIPOLAR DISORDER; CARBAMAZEPINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 7044232087     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D442     Document Type: Article

References (19)

1. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association, 2000.
2. Friedman MJ. Pharmacologic management of posttraumatic stress disorder. Primary Psychiatry 2003;10(8):66-73.
3. Iancu I, Rosen Y, Moshe K. Antiepileptic drugs in posttraumatic stress disorder. Clin Neuropharmacol 2002;25:225-9.
4. Berlant JL. Antiepileptic treatment of posttraumatic stress disorder. Primary Psychiatry 2003;10(10):41-9.
5. Berigan T. Oxcarbazepine treatment of posttraumatic stress disorder (letter). Can J Psychiatry 2002;47:973-4.
6. Mosby's drug consultant. St. Louis: Mosby, 2003:489, 2416.
7. Sadock BJ, Sadock VA. Anxiety disorders. Kaplan & Sadock's synopsis of psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2003:591-642.
8. Lipper S, Davidson JRT, Grady TA, Edinger JD, Hammett EB, Mahorney SL, et al. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-54.
9. Stewart JT, Bartucci BJ. Posttraumatic disorder and partial complex seizures (letter). Am J Psychiatry 1986;143:113-4.
10. Wolf ME, Alavi A, Mosnaim AD. Posttraumatic stress disorder in Vietnam veterans. Clinical and EEG findings; possible therapeutic effects of carbamazepine. Biol Psychiatry 1988;23:642-4.
11. Looff D, Grimley P, Kuller F, Martin A, Shonfield L. Carbamazepine for PTSD (letter). J Am Acad Child Adolesc Psychiatry 1995;34:703-4.
12. Viola J, Ditzler T, Batzer W, Harazin J, Adams D, Lettich L, et al. Pharmacological management of post-traumatic stress disorder: clinical summary of a five-year retrospective study, 1990-1995. Military Med 1997;162:616-9.
13. Post RM, Weiss SRB, Li H, Leverich GS, Pert A. Sensitization components of posttraumatic stress disorder. Implications for therapeutics. Semin Clin Neuropsychiatry 1999;4:282-94.
14. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000;47:769-76.
15. Grant SM, Faulds D. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992;43:873-88.
16. McAuley JW, Biederman TS, Smith JC, Moore JL. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother 2002;36:119-29. DOI 10.1345/aph.10417
17. Tecoma ES. Oxcarbazepine. Epilepsia 1999;40(suppl 5):37-46.
18. Dietrich DE, Kropp S, Emrich HM. Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiatry 2001;34:242-50.
19. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychological Med 1997;27:1079-89.